S Stevanovic

Human peptide transporter deficiency: importance of HLA-B in the presentation of TAP-independent EBV antigens.

J P Cazenave, H. Rammensee, S. Stevanović, 1997, Journal of immunology.

Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids.

M Josten, S. Stevanović, H. Sahl, 1990, European journal of biochemistry.

Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides.

H. Rammensee, S. Stevanović, E. Rieber, 2000, Cancer research.

Analysis of allele-specific contact sites of natural HLA-DR17 ligands.

V. Gnau, H. Rammensee, S. Stevanović, 1994, Journal of immunology.

Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).

D. Jewell, A. Hill, H. Rammensee, 1997, International immunology.

Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.

H. Rammensee, S. Stevanović, L. Kanz, 1999, Blood.

Lectin purified human class I MHC-derived peptides: evidence for presentation of glycopeptides in vivo.

H. Rammensee, S. Stevanović, T. Elliott, 2000, Tissue antigens.

Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two- residue contact motif

S. Stevanović, H. Kalbacher, G. Jung, 1992, The Journal of experimental medicine.